Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Columbia Threadneedle

Columbia Small Cap Value and Inflection Fund Columbia Small Cap Value and Inflection Fund Class A (COVAX)

Ticker COVAX · Since 2002-05-01 · · Holdings as of May 31, 2026

Expense ratio
1.2%$120/yr per $10k
5-yr return
+8.2%annualized
1-yr return
+1.7%as of Dec 2025
Net assets
$868.5Mall share classes
Holdings
102

Bottom line

Is COVAX a good fund? The bottom line

COVAX is a share class of Columbia Small Cap Value and Inflection Fund, an actively managed small-cap mutual fund from Columbia Threadneedle.

Annual fees run 1.2% — about $120 a year on every $10,000 invested, more expensive than 70% of small-cap funds we track.

It returned +1.7% over one year, +8.2% a year over five years, +8.2% a year over ten (as of Dec 31, 2025, per its prospectus).

With $868 million in net assets and 102 holdings, its largest position is Phillips Edison & Co Inc (2.0%) and the top 10 make up 17.1% of the portfolio.

This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.

What to watch

  • Front-end sales load up to 5.75%
  • 12b-1 marketing fee of 0.25% a year
  • High turnover (115% a year) can mean more taxable distributions

Updated Nov 19, 2026

What COVAX invests in

Columbia Small Cap Value and Inflection Fund (the Fund) seeks long-term capital appreciation.

Under normal circumstances, the Fund invests at least 80% of its net assets ( plus the amount of any borrowings for investment purposes) in equity securities of companies that have market capitalizations in the range of the companies in the Russell 2000 Value Index (the Capitalization Index) , which ranged between $ 10.7 million and $ 23.5 billion as of May 31, 2026 , that the Fund ' s investment manager believes are undervalued and have the potential for long-term growth. The market capitalization range and composition of companies in the Capitalization Index are subject to change. As such, the size of the companies in which the Fund invests may change. The Fund may continue to hold a security even if the companys market capitalization is no longer within the range of the Capitalization Index. Under normal circumstances, the Fund also invests at least 80% of its net assets (plus the…

From the fund's prospectus (filed Jun 25, 2026).

COVAX performance

Fund calendar-year total returns, 2016–2025 2016: +23.4%; 2017: +10.6%; 2018: −17.7%; 2019: +20.3%; 2020: +9.9%; 2021: +33.7%; 2022: −13.8%; 2023: +13.7%; 2024: +11.3%; 2025: +7.9% +23% 2016 +11% 2017 −18% 2018 +20% 2019 +10% 2020 +34% 2021 −14% 2022 +14% 2023 +11% 2024 +8% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
COVAX+1.7%+8.2%+8.2%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full COVAX performance history →

What COVAX costs

On a $10,000 investment, COVAX's 1.2% expense ratio costs about $120 a year. The prospectus estimates $2,113 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full COVAX fee table →

COVAX top 10 holdings

#Holding% of fund
1Phillips Edison & Co Inc2.04%
2StoneX Group Inc1.79%
3Polaris Inc1.77%
4Commercial Metals Co1.75%
5BankUnited Inc1.70%
6Texas Capital Bancshares Inc1.66%
7Fulton Financial Corp1.62%
8Synaptics Inc1.60%
9Cabot Corp1.59%
10Essent Group Ltd1.53%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 17.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to COVAX

More funds like COVAX →

COVAX FAQ

What is the expense ratio of COVAX?
COVAX's expense ratio is 1.2%, which works out to about $120 a year for every $10,000 invested. The prospectus estimates total costs of $2,113 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is COVAX a good investment?
It depends on your goals, but the data points to: front-end sales load up to 5.75%; 12b-1 marketing fee of 0.25% a year; high turnover (115% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does COVAX hold?
COVAX's largest holdings are Phillips Edison & Co Inc (2.0%), StoneX Group Inc (1.8%), Polaris Inc (1.8%), Commercial Metals Co (1.8%), BankUnited Inc (1.7%). It holds 102 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is COVAX's 5-year return?
COVAX returned +8.2% a year over the five years ending Dec 31, 2025, and +8.2% a year over ten years. Past performance does not guarantee future results.
Does COVAX have a sales load?
Yes. COVAX has a maximum front-end sales charge of 5.75%. It may charge a deferred sales charge of up to 1% if sold early.
Who manages COVAX?
COVAX is offered by Columbia Threadneedle through Columbia Funds Series Trust.